As of Feb 17
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +46.34% increase from the last price of 4.10.
The current consensus among 2 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since February, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.